Last reviewed · How we verify

NCT01620112

The Effects of Different Clonidine Concentrations on Axillary Brachial Plexus Block With 1,5% Lidocaine for Upper Limb Surgery: a Prospective Randomized Study

Completed Phase 2 Last updated 14 June 2012
What this trial tests

Phase 2 trial testing high Clonidine concentration in Fascicular Block in 60 participants. Completed in 1 July 2011.

Timeline
1 February 2009
Primary endpoint
1 July 2011
1 July 2011

Quick facts

Lead sponsorUniversidade Federal do Rio de Janeiro
PhasePhase 2
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment60
Start date1 February 2009
Primary completion1 July 2011
Estimated completion1 July 2011

Drugs / interventions tested

Conditions studied

Sponsor

Universidade Federal do Rio de Janeiro — full company profile →

Who can join

Adults 18 to 65, any sex, with Fascicular Block or Motor Activity. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Sponsor's own description

The purpose of this study is to determine whether different clonidine concentration on axillary brachial plexus block with 1,5% lidocaine for upper limb surgery may influence the sensory and motor block onset time and duration, postoperative analgesia duration, postoperative pain intensity

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Universidade Federal do Rio de Janeiro trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01620112.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing